Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

101.86 -0.47 (-0.46%)
Official Closing Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,384,634
Open 103.54
Bid (Size) 95.00 (1)
Ask (Size) 105.00 (1)
Prev. Close 102.33
Today's Range 101.82 - 103.60
52wk Range 74.24 - 105.61
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer
Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), citing the company's pipeline as among the best in the space with alpha-emitter-based targeted radionuclide therapies... 
Via Benzinga
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
JMP Securities initiated coverage on Allakos Inc (NASDAQ: ALLK), noting novel monoclonal antibodies targeting Siglec (sialic acid immunoglobulin-like lectin) receptors on immune cells that are drivers... 
Via Benzinga

Performance

YTD
+10.47%
+10.47%
1 Month
+1.37%
+1.37%
3 Month
+3.13%
+3.13%
6 Month
+10.10%
+10.10%
1 Year
+34.01%
+34.01%

More News

Read More
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
Via Benzinga
Health Insurer Centene Streamlines - Plans Massive Layoffs To Cut Costs: Report
Via Benzinga
Topics Workforce
Exposures Layoff
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
Via Benzinga
Novartis Sandoz Prepares For Public Debut With Strong Sales Record And Plans for New Biologic Drugs
Via Benzinga
Are Gene Therapy Stocks The Market's Next Big Winners?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Novartis Precision Cancer Therapy Hits Primary Goal In Rare Type Of Pancreatic Cancer
Via Benzinga
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
Via Talk Markets
AI To Revolutionize Clinical Trials And Diagnostics
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Preventable Vaccines Market May See a Big Move : AstraZeneca, GlaxoSmithKline, Merck
Via SBWire
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
Via Benzinga
Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
Via Benzinga
AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC
Via InvestorPlace
Why Is Canopy Growth (CGC) Stock Up 14% Today?
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff
Via InvestorPlace
Instacart Mulls IPO Price Hike After Arm's Stellar Debut, UAW Launches Historic Simultaneous Strike, China Sanctions Lockheed Martin & Northrop Grumman Concerning Taiwan Arms Sales: Today's Top Stories
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Via Investor's Business Daily
Exposures Product Safety
Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Qualcomm-Apple's Chip Supply Agreement, Alleged Report About AstraZeneca CEO Sir Pascal Soriot's Intention To Step Down, Apple & Google Face Off in Antitrust Showdown: Today's Top Stories
Via Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.